Percutaneous coronary intervention and adjunctive pharmacotherapy in women: a statement for healthcare professionals from the American Heart Association

Percutaneous coronary intervention and adjunctive pharmacotherapy in women: a statement for healthcare professionals from the American Heart Association

16th June 2009
American Heart Association
Summary,

| More

Source: National Guidelines Clearinghouse

DISEASE/CONDITION(S)

  • Fatal and nonfatal ischemic complications in acute myocardial infarction and high-risk acute coronary syndromes (ACS)
Note: Acute coronary syndromes (ACS) are defined as unstable angina (UA) or non-ST-elevation myocardial infarction (NSTEMI)

GUIDELINE CATEGORY
  • Evaluation
  • Management
  • Treatment
CLINICAL SPECIALTY
  • Cardiology
  • Family Practice
  • Internal Medicine
  • Surgery
INTENDED USERS
  • Health Care Providers
  • Physicians
GUIDELINE OBJECTIVE(S)
  • To review what is known and not known about percutaneous coronary intervention (PCI) in women and to put published data in context with contemporary coronary intervention

Copyright® 2004 - 2010 Business Briefings, Ltd. All rights reserved.
Touch Cardiology is for informational purposes and should not be considered medical advice, diagnosis or treatement recommendations.